Consideration of the effect of Artemisia absinthium on eye darkness

Consideration of the effect of an eye cream Artemisia absinthium L. on eye darkness; a double blind randomized clinical trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190413043259N1

Enrollment

Registered

2019-11-03

Start date

2019-04-30

Completion date

Unknown

Last updated

2019-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eye darkness.

Interventions

Intervention 1: 1-Intervention group: 30 member volunteer for a 2 month period, apply twice, daily, eye cream (made in the Faculty Of Traditional Medicine) , In small quantities, which has Absinthium

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Suffering from eye darkness Interesting to participate in this study Age 18-65 both sexes Suffering from eye darkness more than 6 month

Exclusion criteria

Exclusion criteria: Lactation pregnancy Use of solarium or sunbathing and sunburn 3 months prior to the study History of laser treatment or dermabrasion or deep facial peels within the past 3 months

Design outcomes

Primary

Measure	Time frame
Reduction of darkness after using the medication. Timepoint: At the first- 2 weeks-4 weeks- 8 weeks. Method of measurement: Examination by physician- Test by Mexameter divice.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHanan Hamdi

Tehran University of Medical Sciences

hamdi.h@kar.iums.ac.ir+98 21 8899 5636

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026